Trials / Unknown
UnknownNCT05705804
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pitavastatin | Pitavastatin 4 mg will be given. |
| DRUG | Pitavastatin plus Ezetemibe | Pitvastatin 4 mg plus ezetemibe 10 mg will be given. |
| DRUG | Atorvastatin | Atorvastatin 40 mg will be given. |
Timeline
- Start date
- 2023-06-13
- Primary completion
- 2025-02-01
- Completion
- 2025-04-01
- First posted
- 2023-01-31
- Last updated
- 2023-07-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05705804. Inclusion in this directory is not an endorsement.